Common use of Unilateral Termination Clause in Contracts

Unilateral Termination. Either PHS or the Collaborator may unilaterally terminate this entire CRADA at any time by giving written notice at least thirty (30) days prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.1.

Appears in 6 contracts

Sources: Cooperative Research and Development Agreement (Keryx Biopharmaceuticals Inc), Cooperative Research and Development Agreement (Paracelsian Inc /De/), Cooperative Research and Development Agreement (Sequenom Inc)

Unilateral Termination. Either PHS or the Collaborator may unilaterally terminate this entire CRADA at any time by giving written notice at least thirty (30) days prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.1, except that PHS may, at its option, retain funds transferred to PHS prior to unilateral termination by Collaborator for use in completing the Research Plan solely or with another partner.

Appears in 5 contracts

Sources: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement (Newlink Genetics Corp), Cooperative Research and Development Agreement

Unilateral Termination. Either PHS or the Collaborator RPRP or Introgen may unilaterally terminate this entire CRADA at any time by giving written notice at least thirty (30) days prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.1. However, in the event of unilateral termination or early expiration, RPRP's and Introgen's respective obligations under Article 3.6 will survive termination to the extent necessary to complete approved clinical studies under mutually agreed upon protocols.

Appears in 2 contracts

Sources: Cooperative Research and Development Agreement (Introgen Therapeutics Inc), Cooperative Research and Development Agreement (Introgen Therapeutics Inc)

Unilateral Termination. Either PHS CDC or the Collaborator may unilaterally terminate this entire CRADA at any time by giving the written notice at least thirty (30) days prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.111.1.

Appears in 2 contracts

Sources: Cooperative Research and Development Agreement (Progenics Pharmaceuticals Inc), Cooperative Research and Development Agreement (Progenics Pharmaceuticals Inc)

Unilateral Termination. Either PHS NCI or the Collaborator may unilaterally terminate this entire CRADA at any time by giving written notice at least thirty (30) days prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.1.

Appears in 1 contract

Sources: Cooperative Research and Development Agreement (Protarga Inc)

Unilateral Termination. Either PHS Academia Sinica or the Collaborator may unilaterally terminate this entire CRADA at any time by giving written notice at least thirty (30) days prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.111.1.

Appears in 1 contract

Sources: Cooperative Research and Development Agreement

Unilateral Termination. Either PHS NIH or the Collaborator may unilaterally terminate this entire CRADA at any time by giving written notice at least thirty six (306) days months prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.1Article 11.1. K. The following new provision is added to Article 11:

Appears in 1 contract

Sources: Cooperative Research and Development Agreement (Aviron)

Unilateral Termination. Either PHS or the Collaborator may unilaterally terminate this entire CRADA at any time anytime by giving written notice at least thirty (30) days prior to the desired termination date, and any rights accrued in property, patents or other IP rights shall be disposed of as provided in paragraph 10.1.

Appears in 1 contract

Sources: Cooperative Research and Development Agreement (Neopharm Inc)